Cargando…

Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase): Potential Role as a Biomarker in Prostate Cancer

BACKGROUND: The enzyme Arylsulfatase B (ARSB; N-acetylgalactosamine-4-sulfatase) degrades chondroitin-4-sulfate (C4S) and is reduced in malignant colonic and mammary tissues, but has not previously been evaluated in prostate cancer. METHODS: ARSB immunostaining was performed on two tissue microarray...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feferman, Leo, Bhattacharyya, Sumit, Deaton, Ryan, Gann, Peter, Guzman, Grace, Kajdacsy-Balla, Andre, Tobacman, Joanne K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763935/ https://www.ncbi.nlm.nih.gov/pubmed/23835622 http://dx.doi.org/10.1038/pcan.2013.18

Ejemplares similares

Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases
por: Tobacman, Joanne K., et al.
Publicado: (2022)

Increased Cerebral Serum Amyloid A2 and Parameters of Oxidation in Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase)-Null Mice
por: Bhattacharyya, Sumit, et al.
Publicado: (2023)

Restriction of Aerobic Metabolism by Acquired or Innate Arylsulfatase B Deficiency: A New Approach to the Warburg Effect
por: Bhattacharyya, Sumit, et al.
Publicado: (2016)

Decline in arylsulfatase B leads to increased invasiveness of melanoma cells
por: Bhattacharyya, Sumit, et al.
Publicado: (2016)

Abstract 1936: Increases in expression of carbohydrate sulfotransferases CHST11 and CHST15 and decline in N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) require phospho-p38-MAPK following exposure to SARS-CoV-2 spike protein receptor binding domain in human a
por: Tobacman, Joanne, et al.
Publicado: (2023)

Arylsulfatase B Regulates Versican Expression by Galectin-3 and AP-1 Mediated Transcriptional Effects
por: Bhattacharyya, Sumit, et al.
Publicado: (2013)

Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3)
por: Bhattacharyya, Sumit, et al.
Publicado: (2017)

Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF
por: Bhattacharyya, Sumit, et al.
Publicado: (2016)

Hypoxia Reduces Arylsulfatase B Activity and Silencing Arylsulfatase B Replicates and Mediates the Effects of Hypoxia
por: Bhattacharyya, Sumit, et al.
Publicado: (2012)

Increased CHST15 follows decline in arylsulfatase B (ARSB) and disinhibition of non-canonical WNT signaling: potential impact on epithelial and mesenchymal identity
por: Bhattacharyya, Sumit, et al.
Publicado: (2020)

Quantification of the enzyme activities of iduronate-2-sulfatase, N-acetylgalactosamine-6-sulfatase and N-acetylgalactosamine-4-sulfatase using liquid chromatography-tandem mass spectrometry
por: Mashima, Ryuichi, et al.
Publicado: (2017)

Distinct Effects of Carrageenan and High-Fat Consumption on the Mechanisms of Insulin Resistance in Nonobese and Obese Models of Type 2 Diabetes
por: Bhattacharyya, Sumit, et al.
Publicado: (2019)

Exposure to Common Food Additive Carrageenan Alone Leads to Fasting Hyperglycemia and in Combination with High Fat Diet Exacerbates Glucose Intolerance and Hyperlipidemia without Effect on Weight
por: Bhattacharyya, Sumit, et al.
Publicado: (2015)

Recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in the methylotrophic yeast Pichia pastoris
por: Rodríguez-López, Alexander, et al.
Publicado: (2016)

Diagnosing Mucopolysaccharidosis type IV a by the fluorometric assay of N-Acetylgalactosamine-6-sulfate sulfatase activity
por: Shams, Sedigheh, et al.
Publicado: (2017)

Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: Implication in Morquio A disease
por: Khedhiri, Souhir, et al.
Publicado: (2011)

Carrageenan-Free Diet Shows Improved Glucose Tolerance and Insulin Signaling in Prediabetes: A Randomized, Pilot Clinical Trial
por: Feferman, Leo, et al.
Publicado: (2020)

Association of High miR-182 Levels with Low-Risk Prostate Cancer
por: Baumann, Bethany, et al.
Publicado: (2019)

GPX1 Localizes to the Nucleus in Prostate Epithelium and its Levels are not Associated with Prostate Cancer Recurrence
por: Ekoue, Dede N., et al.
Publicado: (2018)

Evidence That Selenium Binding Protein 1 Is a Tumor Suppressor in Prostate Cancer
por: Ansong, Emmanuel, et al.
Publicado: (2015)

Improvement in the production of the human recombinant enzyme N-acetylgalactosamine-6-sulfatase (rhGALNS) in Escherichia coli using synthetic biology approaches
por: Reyes, Luis H., et al.
Publicado: (2017)

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase
por: Harmatz, Paul, et al.
Publicado: (2010)

Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer
por: Ekoue, Dede N., et al.
Publicado: (2018)

Bio-Plex immunoassay measuring the quantity of lysosomal N-acetylgalactosamine-6-sulfatase protein in dried blood spots for the screening of mucopolysaccharidosis IVA in newborn: a pilot study
por: Chuang, Chih-Kuang, et al.
Publicado: (2017)

A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity
por: Bhattacharyya, Sumit, et al.
Publicado: (2017)

Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation
por: Cui, Hao, et al.
Publicado: (2021)

The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates
por: Zhang, Lei, et al.
Publicado: (2022)

A biologically active peptide mimetic of N-acetylgalactosamine/galactose
por: Eggink, Laura L, et al.
Publicado: (2009)

Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins
por: Zhou, Yaxian, et al.
Publicado: (2021)

Changes in plasma arylsulfatase A level as a compensatory biomarker of early Parkinson’s disease
por: Yoo, Han Soo, et al.
Publicado: (2020)

Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice
por: Blomqvist, Maria, et al.
Publicado: (2011)

Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancer
por: Shen, Yiming, et al.
Publicado: (2022)

Unveiling the Shape of N-Acetylgalactosamine: A Cancer-Associated Sugar Derivative
por: Aguado, R., et al.
Publicado: (2022)

Prediction of Prostate Cancer Recurrence Using Quantitative Phase Imaging
por: Sridharan, Shamira, et al.
Publicado: (2015)

High incidence of triple negative breast cancers following pregnancy and an associated gene expression signature
por: Asztalos, Szilard, et al.
Publicado: (2015)

Protein structure prediction for novel mutations in Arylsulfatase-A gene
por: Divya, M, et al.
Publicado: (2014)

Anti-diabetic activity of different oils through their effect on arylsulfatases
por: Samarji, Rima, et al.
Publicado: (2014)

Arylsulfatase A pseudodeficiency in Mexico: Enzymatic activity and haplotype analysis
por: Juárez‐Osuna, Jesús A., et al.
Publicado: (2020)

A Possible Role for Arylsulfatase G in Dermatan Sulfate Metabolism
por: Poterala-Hejmo, Aleksandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8hbsr5d625187p90ksgf5gb9hn